FDA Recalls Neoral Cyclosporine for Out-of-Specification Ethanol Content
Novartis is recalling Neoral cyclosporine 25 mg capsules nationwide due to a manufacturing quality deviation. Lot APCD162 (expiration 01/2023) was found to have out-of-specification ethanol content during stability testing.
- Product
- NEORAL — NEORAL (CYCLOSPORINE)
- Category
- Drug
- Distribution
- Distributed nationwide